Should healthy Medicare beneficiaries postpone enrollment in Medicare Part D?

Adam Atherly and Bryan Dowd
Additional contact information
Adam Atherly: Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA, USA, Postal: Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA, USA
Bryan Dowd: Department of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, USA, Postal: Department of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, USA

Health Economics, 2009, vol. 18, issue 8, pages 921-931

Abstract: We compare estimated lifetime out-of-pocket prescription drug expenditures on outpatient prescription drugs, premiums and late enrollment penalties for healthy 65-year-old Medicare beneficiaries if they (a) purchase Part D as soon as they are eligible versus (b) waiting until they contract a drug-intensive condition. Using data from the Medicare Current Beneficiary Survey, a representative sample of the Medicare population, we estimate the annual probability that a healthy 65-year-old will transition to a drug-intensive health state or death. We then use Monte Carlo simulations to estimate expected lifetime prescription drug spending with and without drug insurance. We find that for the statutory minimum benefit policy with a $30 per month premium, lifetime expected expenditures are about 10% higher for women and 6.5% higher for men if healthy beneficiaries postpone enrollment in Part D. Eliminating the late enrollment penalty would create a significant cost advantage for postponed enrollment, particularly for men. Under current rules, the financial advantage of early enrollment coupled with the reduction in risk associated with purchasing Part D plans and potential utility gains from insurance-induced drug consumption, suggests that immediate purchase of Part D is the optimal choice for Medicare beneficiaries. Copyright © 2008 John Wiley & Sons, Ltd.

Date: 2009
View list of references

Downloads: (external link)
http://hdl.handle.net/10.1002/hec.1413 Link to full text; subscription required (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:wly:hlthec:v:18:y:2009:i:8:p:921-931

Access Statistics for this article

Health Economics is edited by Alan Maynard, John Hutton and Andrew Jones

More articles in Health Economics from John Wiley & Sons, Ltd.
Series data maintained by Christopher F. Baum ().